A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report
Journal of Medical Case Reports, 2007 Background Bupropion is approved for the treatment of mood disorders and as an adjuvant medication for smoking cessation. Bupropion is generally well tolerated and considered safe.
Humayun Fawwaz +3 more
doaj +1 more source
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Addiction, EarlyView.Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper +7 more
wiley +1 more source
Review of bupropion for smoking cessation [PDF]
, 2003 The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major change in the options available for smoking cessation pharmacotherapy.
Zwar, N, Richmond, Robyn
core +1 more source
Bupropion Hydrochloride Induced Serum Sickness-Like Reaction [PDF]
, 2007 Sustained-release bupropion is commonly used for the symptomatic relief of depressive disorders and as an adjuvant in smoking cessation therapy. The frequency of adverse reactions with bupropion has been estimated to be more than 1%.
Yazici, Ayten, Cefle, Ayse
core +3 more sources
Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network. [PDF]
PLoS ONE, 2015 Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of ...
Joshua D Stein +5 more
doaj +1 more source
Addiction, EarlyView.Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati +6 more
wiley +1 more source
Bupropion Overdose Resulted in a Pharmacobezoar in a Fatal Bupropion (Wellbutrin(®) ) Sustained-release Overdose: Postmortem Distribution of Bupropion and its Major Metabolites. [PDF]
, 2017 Bupropion (BUP) overdose commonly causes generalized seizures and central nervous system depression. The case of a 28-year-old woman who died from a massive lethal overdose with sustained-release bupropion (Wellbutrin(®) 300 mg) is herein presented.
Arnaud Capron +7 more
core +1 more source
Varenicline for cannabis use disorder: A randomized controlled trial
Addiction, EarlyView.Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark +8 more
wiley +1 more source
Bupropion interferes with the image diagnosis of Parkinson's disease [PDF]
, 2017 Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung ...
Lane HY, Lin CH
core
The relationship between bupropion and suicide in post-mortem investigations [PDF]
, 2016 We reviewed the 33 727 postmortem toxicology investigations performed in Finland over a period of 5 years (2009-2013) and identified those in which the antidepressant bupropion was detected. Cases positive for other antidepressant drugs were reviewed for
Ojanpera, Ilkka, Kriikku, Pirkko
core +1 more source